文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

68Ga-PSMA PET/CT与mpMRI在前列腺癌放疗计划中GTV勾画的对比分析

Comparative Analysis of 68Ga-Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography and Multiparametric Magnetic Resonance Imaging for Gross Tumor Volume Delineation in Radiation Therapy Planning of Prostate Cancer.
PubMed 文献 · Adv Radiat Oncol · 2025-06-09

该研究回顾性分析了25例前列腺癌患者的68Ga-PSMA PET/CT与mpMRI图像,比较两种方法勾画的肿瘤大体体积(GTV)。

要点

  • PSMA PET/CT衍生的PTV覆盖62%±27%的GTV-MRI,44.4%患者覆盖100%的GTV-MRI。
  • 基于MRI的PTV覆盖50%±31%的GTV-PET,两种方法在47%患者中表现一致。

核心结论

  • 68Ga-PSMA PET/CT与mpMRI在47%患者(40%-54%病灶)中表现一致。
  • GTV-PET显著大于GTV-MRI,提示PSMA PET/CT在前列腺癌靶向放疗计划中可能发挥作用。

研究设计与样本

  • 回顾性分析25例前列腺癌患者,来自2个中心,均接受68Ga-PSMA PET/CT和mpMRI检查。
  • GTV-MRI由2名核医学医师和1名放射肿瘤科医师独立勾画,GTV-PET由2名核医学医师勾画。
  • 为考虑配准不确定性,GTV-PET和GTV-MRI均各向同性外扩5 mm形成PTV,并量化特定PTV与对应GTV的重叠。

主要发现

  • GTV-MRI与GTV-PET的交集为3.5±6.0 cm³。
  • PSMA PET/CT衍生的PTV覆盖GTV-MRI的62%±27%,44.4%患者PTV覆盖100%的GTV-MRI。
  • 基于GTV-MRI的PTV覆盖GTV-PET的50%±31%。

关键数值与推荐

  • GTV-PET与GTV-MRI在47%患者中一致,对应40%-54%的病灶。

临床怎么用

  • PSMA PET/CT可提供比mpMRI更大的GTV,可能有助于靶向放疗剂量递送。
  • 两种模态间存在空间不一致,临床整合时需考虑配准不确定性和外扩边界。

局限性

  • 回顾性设计,样本量25例,来自2个中心。
  • 原文未报告勾画者间一致性分析及长期临床结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Magnetic resonance imaging (MRI) with multiparametric assessment is a cornerstone in radiation therapy planning for primary prostate cancer (PCa), offering the potential for focal dose escalation to dominant intraprostatic lesions to enhance PCa management. The prostate-specific membrane antigen (PSMA), which is frequently overexpressed in PCa, has led to the development of 68Ga-labeled PSMA inhibitors for positron emission tomography (PET)/computed tomography (CT), showing promising results in PCa detection. This study aimed to conduct a comparative analysis of 68Ga-PSMA PET/CT and multiparametric MRI (mpMRI) in delineating the gross tumor volume (GTV) in PCa. METHODS AND MATERIALS: A retrospective analysis was performed on 25 PCa patients who underwent 68Ga-PSMA PET/CT and mpMRI at 2 distinct centers. The GTVs were delineated on MRI (GTV-MRI) by 2 nuclear medicine physicians and 1 radiation oncologist independently, while the GTVs based on PET/CT (GTV-PET) were outlined by 2 nuclear medicine physicians. The laterality (left, right, and bilateral) prostate lobes on mpMRI and PET/CT was assessed. To account for registration uncertainties, both GTV-PET and GTV-MRI were expanded isotropically by 5 mm to form the planning target volume (PTV), and the overlap between specific PTVs and their corresponding GTVs was quantified. RESULTS: The average ± SD GTV-MRI and GTV-PET were 5.468 ± 11.6 cm³ and 11.136 ± 14.3 cm³, respectively, with the GTV-PET being significantly larger than the GTV-MRI (P = .003). GTV-MRI exhibited an intersection with GTV-PET of 3.5 ± 6.0 cm³. The PTV derived from PSMA PET/CT encompassed 62% ± 27% of the GTV-MRI, with 44.4% of patients having the PTV covering 100% of the GTV-MRI. Conversely, the PTV based on GTV-MRI covered 50% ± 31% (mean ± SD) of the GTV-PET. CONCLUSIONS: 68Ga-PSMA PET/CT and mpMRI demonstrated consistent outcomes in 47% of patients (40%-54% of lesions). Notably, the GTV-PET was larger than the GTV-MRI, indicating a potential role for 68Ga-PSMA PET/CT in radiation therapy planning for targeted radiation delivery to PCa.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Bagheri H, Mahdavi SR, Geramifar P, et al. Comparative Analysis of 68Ga-Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography and Multiparametric Magnetic Resonance Imaging for Gross Tumor Volume Delineation in Radiation Therapy Planning of Prostate Cancer. Adv Radiat Oncol. 2025. PMID: 40697967. doi:10.1016/j.adro.2025.101821

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。